SG11201810531TA - Ligand identification by co-fractionation - Google Patents
Ligand identification by co-fractionationInfo
- Publication number
- SG11201810531TA SG11201810531TA SG11201810531TA SG11201810531TA SG11201810531TA SG 11201810531T A SG11201810531T A SG 11201810531TA SG 11201810531T A SG11201810531T A SG 11201810531TA SG 11201810531T A SG11201810531T A SG 11201810531TA SG 11201810531T A SG11201810531T A SG 11201810531TA
- Authority
- SG
- Singapore
- Prior art keywords
- ligands
- international
- potsdam
- macromolecules
- pct
- Prior art date
Links
Classifications
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
- G01N33/536—Immunoassay; Biospecific binding assay; Materials therefor with immune complex formed in liquid phase
- G01N33/537—Immunoassay; Biospecific binding assay; Materials therefor with immune complex formed in liquid phase with separation of immune complex from unbound antigen or antibody
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N1/00—Sampling; Preparing specimens for investigation
- G01N1/28—Preparing specimens for investigation including physical details of (bio-)chemical methods covered elsewhere, e.g. G01N33/50, C12Q
- G01N1/34—Purifying; Cleaning
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N24/00—Investigating or analyzing materials by the use of nuclear magnetic resonance, electron paramagnetic resonance or other spin effects
- G01N24/08—Investigating or analyzing materials by the use of nuclear magnetic resonance, electron paramagnetic resonance or other spin effects by using nuclear magnetic resonance
- G01N24/087—Structure determination of a chemical compound, e.g. of a biomolecule such as a protein
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N24/00—Investigating or analyzing materials by the use of nuclear magnetic resonance, electron paramagnetic resonance or other spin effects
- G01N24/08—Investigating or analyzing materials by the use of nuclear magnetic resonance, electron paramagnetic resonance or other spin effects by using nuclear magnetic resonance
- G01N24/088—Assessment or manipulation of a chemical or biochemical reaction, e.g. verification whether a chemical reaction occurred or whether a ligand binds to a receptor in drug screening or assessing reaction kinetics
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N27/00—Investigating or analysing materials by the use of electric, electrochemical, or magnetic means
- G01N27/62—Investigating or analysing materials by the use of electric, electrochemical, or magnetic means by investigating the ionisation of gases, e.g. aerosols; by investigating electric discharges, e.g. emission of cathode
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
- G01N33/564—Immunoassay; Biospecific binding assay; Materials therefor for pre-existing immune complex or autoimmune disease, i.e. systemic lupus erythematosus, rheumatoid arthritis, multiple sclerosis, rheumatoid factors or complement components C1-C9
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
- G01N33/6803—General methods of protein analysis not limited to specific proteins or families of proteins
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
- G01N33/6803—General methods of protein analysis not limited to specific proteins or families of proteins
- G01N33/6845—Methods of identifying protein-protein interactions in protein mixtures
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
- G01N33/6803—General methods of protein analysis not limited to specific proteins or families of proteins
- G01N33/6848—Methods of protein analysis involving mass spectrometry
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Engineering & Computer Science (AREA)
- Immunology (AREA)
- Physics & Mathematics (AREA)
- Molecular Biology (AREA)
- Chemical & Material Sciences (AREA)
- Hematology (AREA)
- Biomedical Technology (AREA)
- Urology & Nephrology (AREA)
- Biochemistry (AREA)
- Pathology (AREA)
- Analytical Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- General Physics & Mathematics (AREA)
- Medicinal Chemistry (AREA)
- Biotechnology (AREA)
- Food Science & Technology (AREA)
- Microbiology (AREA)
- Cell Biology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- High Energy & Nuclear Physics (AREA)
- Bioinformatics & Computational Biology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Biophysics (AREA)
- Spectroscopy & Molecular Physics (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Rehabilitation Therapy (AREA)
- Rheumatology (AREA)
- Crystallography & Structural Chemistry (AREA)
- Electrochemistry (AREA)
- Investigating Or Analysing Biological Materials (AREA)
- Other Investigation Or Analysis Of Materials By Electrical Means (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| EP16172000 | 2016-05-30 | ||
| PCT/EP2017/062841 WO2017207460A1 (en) | 2016-05-30 | 2017-05-29 | Ligand identification by co-fractionation |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| SG11201810531TA true SG11201810531TA (en) | 2018-12-28 |
Family
ID=56119308
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| SG11201810531TA SG11201810531TA (en) | 2016-05-30 | 2017-05-29 | Ligand identification by co-fractionation |
Country Status (16)
| Country | Link |
|---|---|
| US (1) | US10976310B2 (lt) |
| EP (1) | EP3465207B1 (lt) |
| KR (1) | KR102346785B1 (lt) |
| CN (1) | CN109219750B (lt) |
| AU (1) | AU2017272493B2 (lt) |
| BR (1) | BR112018074856A2 (lt) |
| CA (1) | CA3025711A1 (lt) |
| DK (1) | DK3465207T3 (lt) |
| ES (1) | ES2899110T3 (lt) |
| HU (1) | HUE056359T2 (lt) |
| LT (1) | LT3465207T (lt) |
| PL (1) | PL3465207T3 (lt) |
| PT (1) | PT3465207T (lt) |
| SG (1) | SG11201810531TA (lt) |
| SI (1) | SI3465207T1 (lt) |
| WO (1) | WO2017207460A1 (lt) |
Families Citing this family (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP2022519523A (ja) | 2019-02-08 | 2022-03-24 | デューポイント セラピューティクス， インコーポレイテッド | 化合物の凝縮物に関連する特性を特性評価する方法およびその使用 |
| WO2021055644A1 (en) * | 2019-09-18 | 2021-03-25 | Dewpoint Therapeutics, Inc. | Methods of screening for condensate-associated specificity and uses thereof |
| JP7327096B2 (ja) * | 2019-11-13 | 2023-08-16 | 株式会社島津製作所 | 分子の分離方法 |
| CN113528497B (zh) * | 2021-07-22 | 2022-06-24 | 中国林业科学研究院林业研究所 | Fba8基因或fba8蛋白在制备具有磷酸转移活性和/或蛋白水解活性的试剂中的应用 |
| WO2024112940A1 (en) * | 2022-11-26 | 2024-05-30 | Enveda Therapeutics, Inc. | Methods and systems for identifying compounds for forming, stabilizing or disrupting molecular complexes |
Family Cites Families (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4459359A (en) | 1981-11-19 | 1984-07-10 | New York Blood Center, Inc. | Sensitive immunoassays of antigens or antibodies sequestered within immune complexes |
| AU774776B2 (en) * | 1999-04-15 | 2004-07-08 | University Of Virginia Patent Foundation | Proteome mining |
| EP1556065A4 (en) | 2002-08-14 | 2005-10-19 | Brni Neurosciences Inst | METHOD OF ISOLATING UNDOPPULULATIONS OF PROTEINS WHICH INTERACT IN PROTEIN PROTEIN INTERACTIONS |
| WO2006015796A1 (en) | 2004-08-09 | 2006-02-16 | MAX-PLANCK-Gesellschaft zur Förderung der Wissenschaften e.V. | Method for high-throughput screening of test molecules binding to target molecules |
| US20150105280A1 (en) | 2010-03-10 | 2015-04-16 | Perfinity Biosciences, Inc. | Selector based recognition and quantification system and method for multiple analytes in a single analysis |
| EP2922861A4 (en) | 2012-11-26 | 2016-09-14 | Caris Life Sciences Switzerland Holdings Gmbh | BIOMARKER COMPOSITIONS AND METHODS |
-
2017
- 2017-05-29 KR KR1020187038204A patent/KR102346785B1/ko active IP Right Grant
- 2017-05-29 SI SI201730986T patent/SI3465207T1/sl unknown
- 2017-05-29 CA CA3025711A patent/CA3025711A1/en active Pending
- 2017-05-29 HU HUE17725620A patent/HUE056359T2/hu unknown
- 2017-05-29 LT LTEPPCT/EP2017/062841T patent/LT3465207T/lt unknown
- 2017-05-29 EP EP17725620.3A patent/EP3465207B1/en active Active
- 2017-05-29 DK DK17725620.3T patent/DK3465207T3/da active
- 2017-05-29 ES ES17725620T patent/ES2899110T3/es active Active
- 2017-05-29 CN CN201780034328.7A patent/CN109219750B/zh active Active
- 2017-05-29 BR BR112018074856-0A patent/BR112018074856A2/pt active Search and Examination
- 2017-05-29 AU AU2017272493A patent/AU2017272493B2/en active Active
- 2017-05-29 PL PL17725620T patent/PL3465207T3/pl unknown
- 2017-05-29 PT PT177256203T patent/PT3465207T/pt unknown
- 2017-05-29 WO PCT/EP2017/062841 patent/WO2017207460A1/en unknown
- 2017-05-29 US US16/304,182 patent/US10976310B2/en active Active
- 2017-05-29 SG SG11201810531TA patent/SG11201810531TA/en unknown
Also Published As
| Publication number | Publication date |
|---|---|
| SI3465207T1 (sl) | 2022-01-31 |
| KR102346785B1 (ko) | 2022-01-04 |
| AU2017272493A1 (en) | 2018-12-20 |
| CN109219750A (zh) | 2019-01-15 |
| CA3025711A1 (en) | 2017-12-07 |
| LT3465207T (lt) | 2021-12-10 |
| DK3465207T3 (da) | 2021-11-15 |
| ES2899110T3 (es) | 2022-03-10 |
| PT3465207T (pt) | 2021-11-30 |
| PL3465207T3 (pl) | 2022-01-17 |
| EP3465207A1 (en) | 2019-04-10 |
| AU2017272493B2 (en) | 2021-07-22 |
| HUE056359T2 (hu) | 2022-02-28 |
| US20190361012A1 (en) | 2019-11-28 |
| WO2017207460A1 (en) | 2017-12-07 |
| US10976310B2 (en) | 2021-04-13 |
| EP3465207B1 (en) | 2021-09-01 |
| KR20190013999A (ko) | 2019-02-11 |
| CN109219750B (zh) | 2022-05-31 |
| BR112018074856A2 (pt) | 2019-03-06 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| SG11201810531TA (en) | Ligand identification by co-fractionation | |
| SG11201906341XA (en) | Improved serum albumin binders | |
| SG11201906264YA (en) | Improved serum albumin binders | |
| SG11201810933QA (en) | Anti-c5 antibodies and uses thereof | |
| SG11201909154SA (en) | Bispecific antibodies specifically binding to pd1 and lag3 | |
| SG11201903857UA (en) | Antibodies to pd-1 and uses thereof | |
| SG11201810149VA (en) | Anti hla-g specific antibodies | |
| SG11201807636XA (en) | Process for producing a polyacrylamide solution with increased viscosity | |
| SG11201901834WA (en) | Micrornas as biomarkers for endometriosis | |
| SG11201806190TA (en) | Isotachophoresis for purification of nucleic acids | |
| SG11201900746RA (en) | Engineered antibodies and other fc-domain containing molecules with enhanced agonism and effector functions | |
| SG11201906961UA (en) | Polypeptide variants and uses thereof | |
| SG11201903153PA (en) | Metal recovery process | |
| SG11201907764PA (en) | Methods for screening infections | |
| SG11201811336TA (en) | Method for producing an electrode catalyst from a perovskite metal oxide | |
| SG11201903012RA (en) | Anti-c1s antibodies and methods of use thereof | |
| SG11201907927SA (en) | Binding molecules that specifically bind to tau | |
| SG11201910195WA (en) | Methods for trapping and barcoding discrete biological units in hydrogel | |
| SG11201900618WA (en) | Permanently polarized hydroxyapatite, a process for its manufacture and uses thereof | |
| SG11201809594WA (en) | Nicotine particles and compositions | |
| SG11201809685XA (en) | A method of enhancing the performance of chromatography methods for purification of proteins | |
| SG11201809413RA (en) | Detection of chromosome interaction relevant to breast cancer | |
| SG11201901468SA (en) | Antibodies with reduced binding to process impurities | |
| SG11201807062RA (en) | Anti-tnfalpha-antibodies and functional fragments thereof | |
| SG11201901172QA (en) | A method for manufacturing a fuel component |